Latest

Latest lung disease News | Page 2

  • Latest lung disease news stories and updates. What is happening today? All recent lung disease news and developments. Live coverage and timeline of lung disease. All you need to know about lung disease.
Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01…
Delivering hope: anti-inflammatory drug trial for preterm babies
Datopotamab deruxtecan plus Imfinzi showed promising clinical activity in the first-line advanced non-small cell lung cancer setting in TROPION-Lung04 Phase Ib trial
Outback dad celebrates Father’s Day with pint-sized Jack
Mater Foundation partners with Nine Network for exciting new five year partnership
Extending Dedicated Care For Workers At Risk Of Silicosis
Ozempic is in the spotlight but it’s just the latest in a long and strange history of weight-loss drugs
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
$1.1 million for breakthrough lung disease scanner
Breakthrough lung disease scanner
Omega-3 fatty acids promising for maintaining lung health
Spotlight shines on research and innovation projects
Keep your lungs strong and healthy this winter with Lung Foundation Australia
Retired miners urged to get free lung health checks
Mater launches clinical trial to protect preterm babies
Rainforest plant could hold key to lung fibrosis treatment
Device that can remotely monitor your breathing: as tested on cane toads
Engineered stone may break my bones, but its dust will hurt workers’ lung
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
People who smoke urged to prioritise healthy food not tobacco
Funding for early screening and improved treatments for deadly lung disease
Calls intensify for ban on lethal engineered stone
Major CFMEU rallies across Australia to hit streets as anger rises
Our Make Smoking History team launch ‘Sounds Like’ campaign
Major government funding for Greater Manchester innovation in materials, health and AI
Team Discovers how TKI Cancer Drugs Cause Inflammatory Side Effects
Malfunctioning immune cell behaviour could be drug target in Long Covid
Call for Manchester volunteers in dementia/Alzheimer’s pollution link study
Victoria Backs National Ban On Deadly Engineered Stone
Statement on WHS Ministers’ Meeting
Children’s lung capacity improved in cleaner air
Monash Expert: Concerns grow about silicosis
COVID-19 vaccine available for younger children at higher risk of severe illness
Longstanding WHO partners to enter into official relations with the Organization
Australians deserve more out of Medicare
Discovery could open door to new COPD treatment
Melioidosis cases on rise 30 December
How to protect yourself against bushfire smoke this summer
Less infectious particles from children’s lungs
NIH funds antibiotic trial for HIV and emphysema
Datopotamab deruxtecan showed promising responses as monotherapy and in combination with Imfinzi
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive
Experimental vaccines offer long-term protection against severe COVID
More must be done to manage asbestos risks
Nearly two thirds of Australians are complacent about Covid despite emergence of new wave
Using Vapes May Set Stage for Dental Decay
ATAGI recommendations on use of Pfizer Covid vaccine for children aged 6 months to 4 years
New computational method builds detailed maps of human tissues

© 2024 - The National Tribune Australia